Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferivital is a liposomal iron supplement developed by Nafas Zist Pharmed, specifically formulated for pediatric patients to treat and prevent iron deficiency and iron deficiency anemia. The product utilizes liposomal technology to encapsulate iron, which facilitates absorption through the intestinal mucosa and significantly reduces common side effects such as gastric irritation, constipation, and the unpleasant metallic taste associated with conventional iron salts. In addition to iron, Ferivital typically contains Vitamin B12 and Folic Acid, which act as essential co-factors in the synthesis of red blood cells and hemoglobin, providing a comprehensive approach to managing nutritional anemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ferivital.